Top

Pharmacy Solution for Medication-Assisted Treatment

Offering Stigma-Free Pharmacy Services

Cordant Health Solutions® partners with clinician practices and other stakeholders to provide a pharmacy solution that specializes in safely and securely dispensing medications for medication-assisted treatment (MAT) for opioid and substance use disorders.

Integrating Cordant’s suite of drug testing, pharmacy and data analytics solutions can help promote patient safety, engagement and adherence to treatment protocols and increases visibility into patient behavior for early intervention.

Stigma-Free Buprenorphine Program

Cordant’s buprenorphine distribution program ensures patients receive their medication in a convenient and nonjudgmental environment.

Better Patient Outcomes

Twice as many patients stayed active in treatment when using Cordant's program compared with others.

PDMP Review for Every Prescription

Cordant pharmacists check prescriptions against the state’s prescription drug monitoring program (PDMP) data and alert clinicians to potential risks.

Pharmacy Service in Your Clinic

An on-site Cordant team member may be able to collect drug testing specimens as ordered by the clinician and also deliver prescribed buprenorphine where the program is offered. Onsite delivery services remove many of the barriers treatment patients face that keep them from accessing their medication.

One Pharmacy

Cordant can fill many other maintenance medications for mental health and other chronic conditions, including diabetes (oral medications only), heart disease, high cholesterol, digestive disorders and gastrointestinal diseases, allergies and arthritis.

Cordant’s on-site buprenorphine distribution program in conjunction with your treatment protocol can help improve patient adherence to their treatment plan.

0 %
Improved retention

The on-site program demonstrates significantly higher retention rates for patients early in treatment¹

0 %
Fewer no-shows

Patients are more likely to make their office visits when buprenorphine is dispensed on-site²

0 %
Reduction in ER visits

Fewer patients have drug-related ER visits when utilizing the on-site distribution program²

0 %
Fewer positive opioid tests

Patients experienced fewer relapse events3

1Analysis of 154 patients 90 days or less in treatment prior to on-site program; Nov. 2016–Oct. 2017 and 154 patients 90 days or less in treatment participating in on-site program; Nov. 2017–Oct. 2018
2Analysis of 236 patients in treatment prior to on-site program; Nov. 2016–Oct. 2017 and 300 patients in treatment participating in on-site program; Nov. 2017–Oct. 2018

What Our Patients Are Saying

Please complete this form to request more information about our behavioral health pharmacy service.